Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Oct 1;27(10):573-579.
doi: 10.34172/aim.31725. Epub 2024 Oct 1.

Endotracheal Surfactant and Budesonide Combination Therapy in Neonatal Acute Respiratory Distress Syndrome due to Late-Onset Sepsis

Asli Okbay Gunes  1 , Aydin Bozkaya  1
Affiliations
Observational Study

Endotracheal Surfactant and Budesonide Combination Therapy in Neonatal Acute Respiratory Distress Syndrome due to Late-Onset Sepsis

Asli Okbay Gunes et al. Arch Iran Med. .

Abstract

Background: Neonatal acute respiratory distress syndrome (NARDS) is an important cause of hypoxemic respiratory failure. This study aimed to investigate the short-term effects of endotracheal surfactant and budesonide combination therapy on NARDS secondary to late-onset neonatal sepsis (LONS).

Methods: This was a retrospective, cross-sectional, and observational study. Newborns with NARDS due to LONS who received endotracheal surfactant and budesonide combination therapy between August 2022 and September 2023 were included in this study. Oxygenation status before endotracheal surfactant and budesonide treatment were compared with the values obtained two hours after treatment.

Results: Among 20 neonates, 10 (50%) were diagnosed with severe NARDS, and 10 (50%) were diagnosed with moderate NARDS. The mean corrected gestational age was 33.3±2.9 w when endotracheal surfactant and budesonide were administered to the neonates. The need for the fraction of inspired oxygen (0.75 [0.57-1.00]% vs. 0.55 [0.44-0.80]%; mean difference [MD]: 17.50%, 95% confidence interval [CI]: 14.99 to 22.50) and oxygen saturation index (OSI; 8.03 [4.98-13.94] vs. 4.71 [4.11-8.93]; MD: 2.23, 95% CI: 1.22 to 3.24) decreased (P=0.001 and P<0.001, respectively) after endotracheal surfactant and budesonide treatment. However, preductal oxygen saturation (SpO2 ; 93 [91-94]% vs. 95 [94-96]%; MD: -3.50%, 95% CI: -5.00 to -2.00) increased significantly after endotracheal surfactant and budesonide treatment when compared to pre-treatment values (P<0.001).

Conclusion: The reduction in oxygen demand and OSI, along with an increase in SpO2 after treatment compared to pre-treatment values, suggests that endotracheal surfactant and budesonide combination therapy could be an effective option to improve oxygenation in NARDS secondary to LONS.

Keywords: Acute respiratory distress syndrome; Budesonide; Endotracheal therapy; Neonates; Surfactant.

PubMed Disclaimer

Conflict of interest statement

Competing Interests

The authors declare that they have no conflict of interests.

References

    1. De Luca D, van Kaam AH, Tingay DG, Courtney SE, Danhaive O, Carnielli VP, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med. 2017;5(8):657–66. doi: 10.1016/s2213-2600(17)30214-x. - DOI - PubMed
    1. De Luca D, Tingay DG, van Kaam AH, Courtney SE, Kneyber MC, Tissieres P, et al. Epidemiology of Neonatal acute respiratory distress syndrome: prospective, multicenter, international cohort study. Pediatr Crit Care Med. 2022;23(7):524–34. doi: 10.1097/pcc.0000000000002961. - DOI - PubMed
    1. Cave C, Samano D, Sharma AM, Dickinson J, Salomon J, Mahapatra S. Acute respiratory distress syndrome: a review of ARDS across the life course. J Investig Med. 2024:10815589241270612. 10.1177/10815589241270612. - DOI - PubMed
    1. Shen L, Cai N, Wan S, Chen S. Development and validation of a predictive model for early diagnosis of neonatal acute respiratory distress syndrome based on the Montreux definition. Front Pediatr. 2023;11:1276915. doi: 10.3389/fped.2023.1276915. - DOI - PMC - PubMed
    1. Amigoni A, Pettenazzo A, Stritoni V, Circelli M. Surfactants in acute respiratory distress syndrome in infants and children: past, present and future. Clin Drug Investig. 2017;37(8):729–36. doi: 10.1007/s40261-017-0532-1. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources